NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で240.16%の成長率を示しています。
成長中
同社は成長フェーズにあり、最新の年間収益はUSD 2.56Mに達しています。
割高
同社の最新のPEは-0.03で、過去3年間の水準と比較して高値圏にあります。
機関投資家の買い増し
最新の機関投資家の保有株数は142.96K株で、前四半期比で35.89%増加しています。
バンガードが保有
スター投資家バンガードは本銘柄を0.00株保有しています。
市場活動が低調
同社への投資家の関心は低下しており、20日間の売買回転率は-0.99です。